Imagion Biosystems receives patent from India

Imagion Biosystems Limited, an Australian company dedicated to improving healthcare through the earlier detection of can...

November 14, 2019 | Thursday | News
Spectrum Therapeutics focuses on Real World Evidence research

Spectrum Therapeutics, the medical division of Canopy Growth Corporation (Canopy Growth), is pleased to announce an Aust...

November 12, 2019 | Tuesday | News
Icon Group expands footprint in Asia Pacific

Icon Group (Icon), Australia’s largest dedicated provider of cancer care has announced the completion of a debt ra...

November 11, 2019 | Monday | News
FIND Collaborates with SpeeDx and QuantuMDx

Australia based SpeeDx Pty. Ltd. and UK headquartered QuantuMDx Group Ltd. have announced a collaboration with the Found...

November 7, 2019 | Thursday | News
Icon Group expands cancer care capabilities

Icon Group, Australia's largest dedicated provider of cancer care, with a growing reach into New Zealand&...

November 4, 2019 | Monday | News
Mallinckrodt, Terumo BCT announce UVADEX approval in Australia

Mallinckrodt plc, a global biopharmaceutical company, and Terumo BCT, a global leader in blood component, therapeut...

November 1, 2019 | Friday | News
Kazia raises A$4.0 M to progress R&D programs

Kazia Therapeutics Limited, an Australian oncology-focused biotechnology company, on 28 October 2019, announced that the...

October 29, 2019 | Tuesday | News
Fresenius Medical Care expands services in Western Australia

Fresenius Medical Care, the world's leading provider of dialysis products and services, has announced the further enhanc...

October 30, 2019 | Wednesday | News
World first clinical trial commences in alcohol use disorder

A medication currently used to treat insomnia may also be effective in preventing alcohol intake and relapse in alcohol ...

October 28, 2019 | Monday | News
Osteopore gets recognition for innovative healthcare product

Osteopore, an Australian medical device company that designs and manufactures regenerative implants made via 3D printing...

October 24, 2019 | Thursday | News
NeuClone announces First Human dose of Stelara® (Ustekinumab) Biosimilar candidate

NeuClone, a clinical-stage biopharmaceutical company exclusively focused on developing high-quality biosimilar products,...

October 21, 2019 | Monday | News
Celltrion, Juno establish biosimilar partnership

Celltrion Healthcare Australia (Celltrion) and Juno Pharmaceuticals (Juno) have entered in to a co-marketing partnership...

October 18, 2019 | Friday | News
Admedus inks $A36.2M deal for CardioCel And VascuCel Patch biz

Australia based Admedus Limited announces the sale of its CardioCel® and VascuCel® patch business to U...

October 15, 2019 | Tuesday | News
George Clinical names Sean Hart as Chief Business Officer

George Clinical, a global scientifically-driven clinical research organization (CRO) has announced the promotion of Sean...

October 14, 2019 | Monday | News
Immutep receives A$2.5 M R&D tax incentive from French Govt

Immutep Limited, an Australian biotechnology company developing novel immunotherapy treatments for cancer and autoimmune...

October 14, 2019 | Monday | News
Australia grants Patent to Krystal Biotech

 Krystal Biotech ,a gene therapy company dedicated to developing and commercializing novel treatments for patients ...

October 4, 2019 | Friday | News
InMode opens new subsidiaries in APAC region

Israel based InMode Ltd., a leading global provider of innovative medical technologies, announced that it has completed ...

October 4, 2019 | Friday | News
World-first heart attack alerting technology enters Australia

Hydrix Limited has announced that it has secured the exclusive rights to distribute the AngelMed Guardian® Syst...

October 3, 2019 | Thursday | News